Thomson Reuters Foundation: Can Asia-Pacific region get rid of malaria by 2030? “An ambitious goal — to eliminate malaria from the Asia-Pacific region by 2030 — faces formidable hurdles but is achievable if enough political will and funding are available to fight the mosquito-borne disease, health experts say…” (Zweynert, 2/13).

Wall Street Journal: A Warning From the Heart of Malaria Research “…[Dr. Nick White, chair of the Wellcome Trust Southeast Asian tropical medicine research units,] and others again are gravely concerned that without a push for eradication soon, enough malarial parasites will become resistant to artemisinin that elimination of the…

UCSF Global Health Sciences: Background Paper: The Private Sector’s Role in Malaria Surveillance UCSF Global Health Sciences Global Health Group published a background paper “synthesizing current research and expert knowledge on the current state of the private health sector’s role in malaria surveillance. [The paper discusses] key challenges and how…

Reuters: Gates Foundation awards $50 million to Stanford vaccine discovery “The Bill & Melinda Gates Foundation said on Friday it had awarded Stanford University a $50 million grant to accelerate vaccine development efforts for the world’s most deadly diseases, including AIDS and malaria…” (Cavaliere, 1/30).

Huffington Post: Education, Follow-up Helps Prevent Bed Net Misuse Rev. Larry Hollon, chief executive of United Methodist Communications “Bed nets intended to prevent malaria are used in fishing communities in Zambia to fish for food, which is sold in the local market, according to a report in the New York…

Global Fund to Fight AIDS, Tuberculosis and Malaria: Global Fund News Flash The latest issue of the Global Fund News Flash discusses closing the treatment gap for children with HIV, the role of midwives in efforts to eliminate malaria in Myanmar, and the Fund’s 2015 strategic review (1/29).

New York Times: Hold the Drug, Go Straight to the Source “Ground-up artemisia plants, from which the anti-malaria drug artemisinin is derived, appear to work much better than the refined drug does by itself, according to research at the University of Massachusetts…” (McNeil, 1/26).